Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 3 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Peritoneal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Liver, Cancer of, Primary Resectable 1 Hepatocellular Carcinoma Resectable 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Oxaliplatin 81 S 1 (combination) 55 Capecitabine 44 apatinib 32 Paclitaxel 32 Docetaxel 32 Irinotecan 27 Fluorouracil 22 Drug Therapy 21 sintilimab 20 Cisplatin 20 Leucovorin 16 Hyperthermic Intraperitoneal Chemotherapy 13 XELOX 12 Surgical Procedures, Operative 12 camrelizumab 10 Trastuzumab 10 titanium silicide 9 pembrolizumab 9 Tegafur 9 Nivolumab 9 Neoadjuvant Therapy 9 Laparoscopy 8 Gastrectomy 8 Ramucirumab 7 Folfox protocol 7 Chemotherapy, Adjuvant 7 toripalimab 6 tislelizumab 6 Gastroscopy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Stomach Neoplasms × lobaplatin × Clear all

NCT04808466 2022-02-21

WUHIPEC01

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡